{
 "name": "瑩碩生技",
 "slug": "tw-6677",
 "aliases": [
  "瑩碩生技醫藥股份有限公司",
  "Anxo",
  "6677"
 ],
 "ticker": "6677",
 "industry": "生技醫療業",
 "website": "http://www.anxo.com.tw",
 "summary": "瑩碩生技（6677）是興櫃的生技醫療類股公司，2003 年成立，2018 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "瑩碩生技醫藥股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "Anxo",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2018-06-27",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2003-04-10",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "王建治",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "顏麟權",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 560389500,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "http://www.anxo.com.tw",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：AX251（cariprazine長效針劑）",
   "value": "思覺失調症｜I期（收案中，首例於2026-09-14給藥）｜印度",
   "unit": "",
   "as_of": "2026-09-16",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT07484204",
   "note": "NCT 編號：NCT07484204；as_of 為登錄最後更新公開日。成分取interventions.description，開發及收案地區依試驗登錄；非把美國IND審查國當成試驗地點。"
  },
  {
   "claim": "管線：NTN（nintedanib）",
   "value": "肺纖維化｜2025年9月已向美國FDA提交ANDA｜美國",
   "unit": "",
   "as_of": "2025-11-05",
   "source": "https://www.anxo.com.tw/uploads/ckeditor/files/20251105_瑩碩法說會上傳檔v1.pdf",
   "note": "台灣後續取證不推定美國亦已獲准。"
  },
  {
   "claim": "管線：AX182",
   "value": "高血脂｜台灣已開發上市，已技轉CTI進行美國開發｜台灣、美國",
   "unit": "",
   "as_of": "2025-11-05",
   "source": "https://www.anxo.com.tw/uploads/ckeditor/files/20251105_瑩碩法說會上傳檔v1.pdf"
  },
  {
   "claim": "管線：AX254",
   "value": "思覺失調症｜處方開發及臨床前試驗完成，專利布局中｜地區未公開",
   "unit": "",
   "as_of": "2025-11-05",
   "source": "https://www.anxo.com.tw/uploads/ckeditor/files/20251105_瑩碩法說會上傳檔v1.pdf"
  },
  {
   "claim": "催化劑：NTN",
   "value": "美國ANDA目標取證｜2027上半年（公司預估）｜已公告",
   "unit": "",
   "as_of": "2025-11-05",
   "source": "https://www.anxo.com.tw/uploads/ckeditor/files/20251105_瑩碩法說會上傳檔v1.pdf",
   "note": "目標取證，不是FDA已承諾核准日。"
  },
  {
   "claim": "催化劑：AX182",
   "value": "美國目標取證｜2027Q3（公司預估）｜已公告",
   "unit": "",
   "as_of": "2025-11-05",
   "source": "https://www.anxo.com.tw/uploads/ckeditor/files/20251105_瑩碩法說會上傳檔v1.pdf",
   "note": "目標取證，不是主管機關審查目標日。"
  },
  {
   "claim": "授權合作：MPH／益釋寧（methylphenidate）",
   "value": "丸仁製藥 WhanIn Pharm. Co., Ltd.｜韓國｜2025-10-29",
   "unit": "",
   "as_of": "2025-10-29",
   "source": "https://www.anxo.com.tw/news/view/220",
   "note": "公司原文「今」簽署合約。包含簽約金/里程碑/供貨收入但未揭露金額，不把市場規模視為交易金額。"
  },
  {
   "claim": "授權合作：益利舒持續釋放口溶錠",
   "value": "YS Life Science｜韓國｜2026-09-16",
   "unit": "",
   "as_of": "2026-09-16",
   "source": "https://www.anxo.com.tw/news/view/231",
   "note": "公司原文「今」簽署合約。包含簽約金/里程碑/供貨收入但未揭露金額，不把市場規模視為交易金額。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6677.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}